Synthesis and Evaluation of Benzimidazole Derivatives as Selective COX-2 Inhibitors

ISSN: 1875-6638 (Online)
ISSN: 1573-4064 (Print)


Volume 10, 8 Issues, 2014


Download PDF Flyer




Medicinal Chemistry

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK
Email: mc@benthamscience.org

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.387
5 - Year: 1.379

Synthesis and Evaluation of Benzimidazole Derivatives as Selective COX-2 Inhibitors

Author(s): Ankita Rathore, Mujeeb -Ur- Rahman, Anees A. Siddiqui, Abuzer Ali and Mohammad Shahar Yar

Affiliation: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard (Hamdard University), New Delhi-110062, India

Abstract

A new series of 1-{(5-substituted-alkyl/aryl-1,3,4-oxadiazol-2-yl)methyl}-2-(piperidin-1-ylmethyl)-1H-benzimidazoles (5a-5r) was synthesized and screened for their inhibitory activity against COX (1 and 2). In-vivo anti-inflammatory activity of potent compounds was done by carrageenan-induced rat paw edema model. In-vitro anticancer activity of synthesized compounds was also performed at the National Cancer Institute (NCI) against NCI 60 cell lines panel. Out of 18 compounds screened, 5h, 5i, 5j and 5l were found to be potent COX-2 inhibitors in the range of IC50 0.06–0.81 µM. In vivo anti-inflammatory screening results revealed that the compounds 5h and 5j manifested profound percent protection of 72.8 and 75.0%, respectively. Compound 5f exhibited moderate cytotoxicity with 58.79% growth inhibition against SNB-75 (CNS Cancer) cell lines and moderate activity against COX-2 (IC50 = 8.0 µM)


Purchase Online Rights and Permissions

  
  



Article Details

Volume: 10
First Page: 1
Page Count: 1
DOI: 10.2174/1573406410666140815121613
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science